Genetic and Epigenetic Alterations in Bladder Cancer
- PMID: 27915480
- PMCID: PMC5169086
- DOI: 10.5213/inj.1632752.376
Genetic and Epigenetic Alterations in Bladder Cancer
Abstract
Bladder cancer is one of the most common cancers worldwide, with a high rate of recurrence and poor outcomes as a result of relapse. Bladder cancer patients require lifelong invasive monitoring and treatment, making bladder cancer one of the most expensive malignancies. Lines of evidence increasingly point to distinct genetic and epigenetic alteration patterns in bladder cancer, even between the different stages and grades of disease. In addition, genetic and epigenetic alterations have been demonstrated to play important roles during bladder tumorigenesis. This review will focus on bladder cancer-associated genomic and epigenomic alterations, which are common in bladder cancer and provide potential diagnostic markers and therapeutic targets for bladder cancer treatment.
Keywords: DNA Methylation; Epigenetic Therapy; Epigenetics, Genetic; Urinary Bladder Neoplasms.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Cancer facts & figures 2016 [Internet] Atlanta (GA): American Cancer Society; 2016. [cited 2016 Aug 28]. Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2...
-
- Surveillance, Epidemiology, and End Results. SEER stat fact sheets: bladder cancer [Internet] Bethesda (MD): National Cancer Institute; 2016. [cited 2016 Aug 28]. Available from: http://seer.cancer.gov/statfacts/html/urinb.html.
-
- Brandau S, Böhle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol. 2001;39:491–7. - PubMed
-
- Feng Z, Hu W, Rom WN, Beland FA, Tang MS. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis. 2002;23:1721–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
